Veterinary Medicines

BIOCAN DHPPI Λυοφιλοποιημένο υλικό και διαλύτης για ενέσιμο εναιώρημα

Authorised
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
  • Canine parvovirus, strain CPV-Bio 12, Live
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
  • Canine distemper virus, strain CDVU 39, Live
Download as PDF

Product identification

Medicine name:
BIOCAN DHPPI Λυοφιλοποιημένο υλικό και διαλύτης για ενέσιμο εναιώρημα
Active substance:
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
  • Canine parvovirus, strain CPV-Bio 12, Live
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
  • Canine distemper virus, strain CDVU 39, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
    1000.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine parvovirus, strain CPV-Bio 12, Live
    31622.80
    50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
    3162.28
    50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine distemper virus, strain CDVU 39, Live
    1000.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 69250/19-06-2025/K-0267201
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 10/08/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 10/08/2023
Download